Table 1.
Characteristic | |
---|---|
All participants, baseline salivary shedding | 48/127 (38)a |
Age (median, 35 yrs; IQR, 29-43 yrs) | |
< 30 | 14/32 (44) |
30-39 | 18/43 (42) |
40-49 | 13/45 (29) |
50+ | 3/7 (43) |
Race | |
White | 1/5 (20) |
Black | 22/55 (40) |
Hispanic | 25/66 (38) |
Other | 0/1 (0) |
AIDS | |
No | 35/98 (36) |
Yes | 13/29 (45) |
CD4+ cells (median, 400; IQR, 246-551) | |
500+ | 7/38 (18) |
350-499 | 10/38 (26) |
200-349 | 19/30 (63) |
< 200 | 12/21 (57) |
HIV-1 RNA in plasma (median, 1055; IQR, 80-13,000) | |
< 1000 | 5/63 (8)b |
1000-9999 | 16/30 (53) |
10,000+ | 26/33 (79) |
ARV therapy | |
None | 25/42 (60) |
Mono/Combo | 5/16 (31) |
HAART | 18/69 (26) |
No. with salivary shedding/total no. in demographic category (percent with salivary shedding).
One participant with missing viral load at baseline.
Viral load in plasma was censored at 80 copies/mL.